Illumina has a new addition to its portfolio: genomic compression-software company Enancio, based in Cesson-Sévigné, France.
Metrohm Australia has announced that, as of 1 March 2020, it is the exclusive distributor for ELGA LabWater in Australia for the PURELAB and CENTRA ranges.
Abcam has announced the asset purchase of the gene editing platform and oncology product portfolio of Applied StemCell for life science research and diagnostic markets.
Abcam has announced the successful completion of the acquisition of Expedeon's Proteomics and Immunology business, which includes Innova and TGR Biosciences, as of 1 January 2020.
The Alvéole platform allows users to convert an existing microscope into an automated bioengineering system for the engineering of smart cell culture substrates.
Abcam has announced its acquisition of the entire live cell line and lysates portfolio of EdiGene, a Chinese company focused on developing genome editing technologies into novel therapeutics.
Agilent Technologies has signed a definitive agreement to acquire the privately owned BioTek Instruments for $1.165 billion.
AXT has signed an agreement to distribute stem cell solutions from StemBioSys to researchers in Australia and New Zealand.
Thermo Fisher Scientific has completed its acquisition of HighChem but terminated the agreement under which it would have acquired Gatan.
AMS Instrumentation & Calibration has been appointed the exclusive distributor for the Bronkhorst range of thermal, Coriolis and ultrasonic flowmeters and controllers for low flow rates of gases and liquids in Australia and its territories.
SCHOTT, an international technology group in the areas of specialty glass and glass ceramics, has entered into a purchase agreement to acquire Australian microfluidic company MINIFAB.
Scientific equipment supplier AXT has announced the formation of a new relationship with US-based Direct Electron — a producer of next-generation detection cameras for transmission electron microscopes (TEM).
Thermo Fisher Scientific has entered into a definitive agreement to acquire Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for US$1.7 billion in cash.
AXT has signed an exclusive distribution agreement with ELEMISSION, a Canadian-based company that specialises in large-scale micro characterisation using continuous LIBS (laser-induced breakdown spectroscopy) scanning technology.
Arrow Pharmaceuticals and Apotex Australia have announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations.